» Authors » Motoi Azumi

Motoi Azumi

Explore the profile of Motoi Azumi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 45
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishikawa T, Ohashi K, Kodama E, Kobayashi T, Azumi M, Nozawa Y, et al.
Gastro Hep Adv . 2024 Aug; 1(3):431-436. PMID: 39131674
Background And Aims: The prognosis of acute liver failure (ALF) treated with conservative therapy is extremely poor. Histologic diagnosis at the time ALF occurs provides important clues for determining the...
2.
Sano T, Ishikawa T, Azumi M, Sato R, Jimbo R, Kobayashi Y, et al.
Medicine (Baltimore) . 2023 Sep; 102(37):e35092. PMID: 37713820
This study aimed to investigate the risk factors for difficult endoscopic hemostasis in patients with colonic diverticular bleeding and to evaluate the efficacy and safety of transcatheter arterial embolization (TAE)...
3.
Ishikawa T, Kodama E, Kobayashi T, Azumi M, Nozawa Y, Iwanaga A, et al.
Ann Palliat Med . 2023 Feb; 12(3):448-457. PMID: 36786095
Background: Transarterial chemoembolization (TACE) is the standard treatment for Barcelona Clinic Liver Cancer (BCLC)-B hepatocellular carcinoma (HCC). A novel glass membrane emulsification device (GMD) produces a high percentage of water/oil...
4.
Ishikawa T, Ohashi K, Kodama E, Kobayashi T, Azumi M, Nozawa Y, et al.
Medicine (Baltimore) . 2022 Oct; 101(40):e30985. PMID: 36221332
Blood transfusion, splenectomy, and partial splenic embolization (PSE) are generally performed for thrombocytopenia in patients with cirrhosis. Recently, thrombopoietin (TPO) agonists have become available, and investigations of patients who would...
5.
Ishikawa T, Kodama E, Kobayashi T, Azumi M, Nozawa Y, Iwanaga A, et al.
Ann Palliat Med . 2022 Jul; 11(8):2658-2667. PMID: 35815452
Background: Mac-2-binding protein glycosylation isomer (M2BPGi), a novel noninvasive biomarker for fibrosis, is a prognostic factor for liver disease; however, its relationship with hepatic function reserve and nutritional status remains...
6.
Ishikawa T, Kodama E, Kobayashi T, Azumi M, Nozawa Y, Iwanaga A, et al.
Cancer Diagn Progn . 2022 Apr; 1(5):411-416. PMID: 35403163
Background/aim: Tumor biopsy are needed frequency for accurate diagnosis. However, percutaneous liver tumor biopsy presents a risk of complications such as bleeding and tumor seeding. We investigated the feasibility of...
7.
Ishikawa T, Imai M, Endo S, Azumi M, Nozawa Y, Iwanaga A, et al.
Ann Palliat Med . 2022 Jan; 11(6):1954-1960. PMID: 35073712
Background: Interventional radiology (IVR), including balloon-occluded retrograde transvenous obliteration (BRTO) and percutaneous transhepatic obliteration (PTO), is performed for patients with intractable hepatic encephalopathy (HE). However, information on the appropriate coil...
8.
Ishikawa T, Kodama E, Kobayashi T, Azumi M, Nozawa Y, Iwanaga A, et al.
Cureus . 2021 Dec; 13(11):e19555. PMID: 34917436
Introduction Transjugular liver biopsy (TJLB) is indicated for patients in whom percutaneous liver biopsy is contraindicated, such as those with hematological diseases complicated by liver dysfunction. However, the clinical utility...
9.
Kobayashi T, Takeuchi M, Hojo Y, Ishii Y, Koseki Y, Kobayashi Y, et al.
J Gastrointest Oncol . 2021 Sep; 12(4):1518-1530. PMID: 34532107
Background: Current guidelines recommend the temporary discontinuation of anticoagulants before colonoscopic polypectomy, but the effect of this practice on reducing the risk of delayed bleeding after hot snare polypectomy (HSP)...
10.
Sano T, Nozawa Y, Iwanaga A, Azumi M, Imai M, Ishikawa T, et al.
Mol Clin Oncol . 2021 Jul; 15(2):170. PMID: 34295470
The current study aimed to compare the safety and effectiveness of self-expandable metallic stent placement among patients with extracolonic malignancy and those with colorectal cancer. Patient information, technical and clinical...